← back to search

Andrea Mattevi

University of Vermont · US
Area of research
Biochemistry · Molecular Biology
Research interest
Research interests include Chemistry, Biochemistry, Biology, Demethylase, Cofactor, and Mycobacterium tuberculosis.
h-index
citations
1,184
works
16
NIH funding
primary concept
email

Recent publications

UM171 glues asymmetric CRL3–HDAC1/2 assembly to degrade CoREST corepressors
Nature 2025cited by 46position: middledoi
Uncovering a Mutation-Independent Therapeutic Strategy against Inherited Retinal Diseases: Development of Class I HDAC/LSD1 Hybrid Inhibitors
ACS Chemical Neuroscience 2025cited by 1position: middledoi
AI is a viable alternative to high throughput screening: a 318-target study
Scientific Reports 2024cited by 119position: middledoi
Uncoupling histone modification crosstalk by engineering lysine demethylase LSD1
Nature Chemical Biology 2024cited by 19position: middledoi
An Elegant Four-Helical Fold in NOX and STEAP Enzymes Facilitates Electron Transport across Biomembranes—Similar Vehicle, Different Destination
Accounts of Chemical Research 2020cited by 31position: lastdoi
On the mechanism of calcium‐dependent activation of NADPH oxidase 5 (NOX5)
FEBS Journal 2019cited by 42position: lastdoi
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
Nature Communications 2018cited by 231position: middledoi
Cryo-EM structures of human STEAP4 reveal mechanism of iron(III) reduction
Nature Communications 2018cited by 83position: middledoi
Monoamine Oxidases, Oxidative Stress, and Altered Mitochondrial Dynamics in Cardiac Ageing
Oxidative Medicine and Cellular Longevity 2017cited by 110position: middledoi
MCM5: a new actor in the link between DNA replication and Meier-Gorlin syndrome
European Journal of Human Genetics 2017cited by 77position: middledoi
A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors
ACS Infectious Diseases 2017cited by 39position: middledoi
Protein Recognition by Short Peptide Reversible Inhibitors of the Chromatin-Modifying LSD1/CoREST Lysine Demethylase
ACS Chemical Biology 2013cited by 66position: lastdoi
Crystal Structure of 3-Hydroxybenzoate 6-Hydroxylase Uncovers Lipid-assisted Flavoprotein Strategy for Regioselective Aromatic Hydroxylation
Journal of Biological Chemistry 2013cited by 52position: middledoi
Expanding the Druggable Space of the LSD1/CoREST Epigenetic Target: New Potential Binding Regions for Drug-Like Molecules, Peptides, Protein Partners, and Chromatin
PLoS Computational Biology 2013cited by 31position: middledoi
Structural Basis for Benzothiazinone-Mediated Killing of <i>Mycobacterium tuberculosis</i>
Science Translational Medicine 2012cited by 218position: middledoi
Precursor of ether phospholipids is synthesized by a flavoenzyme through covalent catalysis
Proceedings of the National Academy of Sciences 2012cited by 19position: lastdoi

Grants

No grants ingested yet.

Frequent collaborators

· 3 papers (2012–2017)Dale E. Edmondson · Emory University3 papers (2012–2017) · 2 papers (2013–2013)Wout Oosterheert · Utrecht University2 papers (2018–2020)Riccardo Baron · University of Utah2 papers (2013–2013) · 2 papers (2012–2017)Piet Gros · Utrecht University2 papers (2018–2020) · 2 papers (2012–2017)Nadeem A. Vellore · Johnson & Johnson (United States)2 papers (2013–2013) · 2 papers (2013–2013)Giulia Degiacomi · University of Padua2 papers (2012–2017) · 2 papers (2012–2017) · 2 papers (2012–2017)A. Ganesan · University of Southampton2 papers (2013–2013)Marcello Tortorici · Institut Pasteur2 papers (2013–2013) · 2 papers (2024–2025) · 1 papers (2025–2025) · 1 papers (2017–2017)Philip A. Cole · Brigham and Women's Hospital1 papers (2024–2024) · 1 papers (2013–2013)